- Home
- / Evelo Therapeutics
Evelo Therapeutics
Total Funding
$35 M
Evelo Therapeutics Summary
Company Summary
- Overview
- Evelo Therapeutics has built a proprietary discovery, design and development platform based on a deep understanding of cancer associated bacteria (CAB) and bacterial immune activators (BIA™) to develop microbiome based therapies for cancer.
- Type
- Private
- Status
- Closed
- Founded
- 2014
- HQ
- Cambridge, MA, US | view all locations
- Website
- http://evelotx.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Cambridge, MA HQ
United States
620 Memorial Dr
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026